Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 11
Tables & Figures: 150
Countries covered: 19
Pages: 130
Download Free PDF

Rigid Endoscopes Market
Get a free sample of this reportGet a free sample of this report Rigid Endoscopes Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Rigid Endoscopes Market Size
The global rigid endoscopes market was estimated at USD 10.4 billion in 2024. The market is expected to grow from USD 11 billion in 2025 to USD 20 billion in 2034, growing at a CAGR of 6.8%. The growing prevalence of chronic ailments coupled with the rising geriatric population is one of the key variables driving industry growth. Endoscopy procedures that utilize rigid endoscopes are crucial in the management or treatment of multiple health conditions, including digestive tract-related infections, chronic obstructive pulmonary disease (COPD), and common ENT problems among others.
Rigid endoscopes are smart medical devices with a straight, inflexible tube used to visually examine internal organs and perform minimally invasive surgeries. They provide high-resolution imaging and are mostly used in procedures involving the bladder, joints, abdominal cavity and uterus. The market growth is strongly attributed to the rising demand for minimally invasive surgical procedures, which offer faster recovery times and reduced complications. Major players in the industry include Ambu, B. Braun, Boston Scientific, Cook, Fujifilm, and Olympus.
The market saw growth from USD 8.3 billion in 2021 to USD 9.8 billion in 2023, registering a positive CAGR of 8.9% during this period. The rising prevalence of chronic diseases like autoimmune disorders, diabetes, and cancer where patients prefer self-administration over hospital visits, is a major contributing factor to the market growth. The rigid endoscopes market is being driven by a combination of increasing surgical volumes, rising prevalence of chronic diseases, and advances in minimally invasive technologies. The rising global cancer burden is one of the main contributors, according to Cancer Tomorrow, there were about 13.3 million cancer cases in 2020, and by 2040, that number is predicted to more than double to 30.3 million.
One of the key contributors is the growing global cancer burden according to Cancer Tomorrow, cancer cases were around 13.3 million in 2020 and are expected to more than double to 30.3 million by 2040. This surge in cancer incidence is anticipated to increase demand for surgical interventions and biopsy, where rigid endoscopes play a vital role in treatment and diagnosis.
Additionally, women’s health issues are enhancing market demand. WHO reported in 2021 that approximately 190 million women suffer from endometriosis, a condition often requiring laparoscopic intervention using rigid scopes. Similarly, a 2022 study revealed that the likelihood of uterine fibroids (UFs) ranges between 20-77%, particularly affecting women health under 35 (40-60%) and over 50 (up to 80%), with Black women in the U.S. having a 59% occurrence rate. These conditions often require endoscopic treatment. Post-pandemic trends also indicate a sharp rebound in elective surgeries, further fueling adoption. Coupled with advancements in HD and 4K imaging and the expansion of ambulatory surgical centers, these factors are creating robust momentum for the rigid endoscopes market.
Rigid endoscopes are medical devices that provide sharp, high-resolution images while viewing and operating inside the body through tiny incisions. They are perfect for procedures in places like the abdomen, joints, or reproductive organs during minimally invasive surgeries because, in unlike flexible scopes, they have a solid, straight design that offers stability and precision.
Rigid Endoscopes Market Trends
The market is experiencing robust momentum, shaped by a complex interplay of macroeconomic forces, evolving healthcare infrastructure, micro-level provider behaviors, and rapid technological breakthroughs. At the macro level, the sustained global increase in surgical volumes driven by demographic shifts like aging populations, growing prevalence of chronic diseases, and rebound of elective procedures post-pandemic is a major catalyst.
Rigid Endoscopes Market Analysis
The global market was valued at USD 8.3 billion in 2021. The market size reached USD 9.8 billion in 2023, from USD 9.1 billion in 2022.
Based on the device type, the market is segmented into laparoscopes, arthroscopes, ENT endoscopes, cystoscopes, pulmonary endoscopes, ureteroscopes, hysteroscopes, and other product types. The laparoscopes segment accounted for 32.5% of the market in 2024 due to the rising preference for minimally invasive surgeries that offer faster recovery, reduced hospital stays, and lower post-operative complications.
The segment is expected to exceed USD 6.6 billion by 2034, growing at a CAGR of 6.9% during the forecast period. On the other hand, arthroscopes segment is expected to grow with a CAGR of 7.9%. The growth of this segment can be attributed to the rising incidence of sports injuries and joint disorders, coupled with growing demand for minimally invasive orthopedic procedures.
Based on technology, the rigid endoscopes market is segmented into video endoscopes, conventional endoscopes, and fiber-optic endoscopes. The video endoscopes segment accounted for the highest market share of 56.3% in 2024 due to its superior image clarity, real-time visualization, and enhanced documentation capabilities, which significantly improve diagnostic accuracy and surgical precision.
Based on usability, the rigid endoscopes market is bifurcated into reusable endoscopes, and disposable endoscopes. The reusable endoscopes segment accounted for the highest market share of 80.3% in 2024, driven by their cost-effectiveness, durability, and widespread adoption across hospitals and surgical centers for repeated procedures.
Based on the end use, the rigid endoscopes market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for the highest market share of 61% in 2024 driven by high surgical volumes, advanced infrastructure, and greater adoption of minimally invasive procedures requiring rigid endoscopes.
North America dominated the global rigid endoscopes market with the highest market share of 42% in 2024.
Europe rigid endoscopes market accounted for USD 2.2 billion in 2024.
The Asia Pacific rigid endoscopes market is anticipated to witness high growth over the analysis timeframe.
The Latin America rigid endoscopes market is anticipated to witness high growth over the analysis timeframe.
Rigid Endoscopes Market Share
Leading companies like Olympus Corporation, Karl Storz, Stryker together hold between 25% - 30% of the market share in the moderately consolidated global market. These players maintain their competitive edge through continuous innovation, global distribution networks, and deep clinical expertise across multiple surgical specialties. Olympus, for example, has remained a dominant force in both gastrointestinal and laparoscopic endoscopy through the integration of high-definition and 4K imaging systems, offering enhanced visibility during complex surgeries.
Karl Storz continues to strengthen its foothold through specialized product portfolios in urology, gynecology, and arthroscopy, while also leveraging modular system design to appeal to ambulatory surgical centers and outpatient clinics.
Stryker, on the other hand, has gained prominence through its focus on ergonomic endoscopic platforms and advanced visualization systems, which are widely adopted in orthopedic and ENT procedures.
Aside from these leaders, other notable players such as Richard Wolf, Boston Scientific, PENTAX Medical, ConMed, Smith & Nephew, B. Braun and others are increasing their market share through regional expansion and targeted innovations. The market also sees growing activity from emerging Asian manufacturers offering cost-competitive solutions, especially in price-sensitive regions like Latin America, Southeast Asia, and parts of Eastern Europe.
As of 2023, the market is projected over the next several years, indicating ample opportunities for both established and emerging players. Strategic mergers, acquisitions, and research and development investments continue to shape the competitive landscape, making innovation and localization key pillars of sustained market presence.
Rigid Endoscopes Market Companies
Few of the prominent players operating in the rigid endoscopes industry include:
Ambu A/S stands out with its focus on single-use endoscopy solutions that reduce infection risks and eliminate reprocessing costs. Its innovation in sterile, portable endoscopic technology supports high-volume clinical settings, especially in emergency care and outpatient environments, positioning Ambu as a disruptor in conventional rigid endoscope applications.
B. Braun leverages its expertise in surgical instrumentation to offer robust and ergonomic rigid endoscopes, particularly in laparoscopic and urological procedures. Its systems integrate seamlessly with OR setups, emphasizing safety, hygiene, and precision. The company’s focus on training, service, and integrated solutions enhances its value in hospital partnerships.
Boston Scientific differentiates itself through a strong focus on minimally invasive therapies, including urology and gynecology. While more active in flexible endoscopy, its rigid systems benefit from the company’s innovation in optics and surgical access tools. Its global footprint and clinician-focused research and development strengthen its appeal in hospital procurement decisions.
Stryker is known for its high-performance rigid endoscope platforms with advanced 4K imaging and ergonomic designs tailored for precision and surgeon comfort. Its integration with digital OR solutions and navigation systems enhances workflow efficiency. Stryker’s strong brand presence and innovation pipeline make it a top choice in orthopedic and ENT surgeries.
Rigid Endoscopes Industry News:
The rigid endoscopes market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
Market, By Technology
Market, By Usability
Market, By End Use
The above information is provided for the following regions and countries: